2019-09-19 12:09:06 |
ASX Notice - Admission and Quotation (23/09/2019) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e9999d5e20755b6abe6622301d54a5b6 |
Admission to Official List
Commencement of Official Quotation
|
2019-09-19 12:15:13 |
Admission to Official List |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1931b979f686ba39020f8c407807feea |
Admission to Official List
|
2019-09-19 12:20:18 |
Appendix 1A and Information Form and Checklist |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd99622d117b8e3c890d2d47751e3f03 |
Admission to Official List
Company Administration - Other
|
2019-09-19 12:22:20 |
Replacement Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8afe8d7118a11560f0df301540cd63c6 |
Admission to Official List
|
2019-09-19 12:27:21 |
Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c6113dc214cfe8c7249e31de676c8d2d |
Admission to Official List
|
2019-09-19 12:29:26 |
Osteopore Limited - Interim Financial report 30 June 2019 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6c89db0dadae7b12cdb632fe5f3d624b |
Admission to Official List
|
2019-09-19 12:32:30 |
Osteopore International Pte Ltd Accounts 31 December 2017 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63271d063d39977a6aaf066296555d87 |
Admission to Official List
|
2019-09-19 12:36:32 |
Osteopore International Pte Ltd Accounts 31 December 2018 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e540687bc536e22d6805bac7c421e73 |
|
2019-09-19 12:42:38 |
Osteopore International Pte Ltd Interim Accounts 30/06/2019 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e25f82a9e08400cd1ad2a1b1754bb17d |
|
2019-09-19 12:43:41 |
Employee Securities Incentive Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0859808af4bee603728819dad27c490 |
Admission to Official List
Company Administration - Other
|
2019-09-19 12:44:42 |
Securities Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9a018dc3eb1d3f0342c25a31b98e591 |
|
2019-09-19 12:46:44 |
Top 20 Shareholders and Distribution Schedule |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f1892e08aa6e627fa37b49638f199a95 |
Admission to Official List
|
2019-09-19 12:47:45 |
Restricted Securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fcb8e21a5f003b0c7ae67c03b306e90c |
Admission to Official List
|
2019-09-19 12:50:46 |
Capital Structure |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f67f51d86aa29ae011cb8caee3b91fa3 |
Admission to Official List
Company Administration - Other
|
2019-09-19 12:51:47 |
Confirmation Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/05326b46fc0c32ee9ef6ecc516d13160 |
Admission to Official List
Company Administration - Other
|
2019-09-23 09:38:08 |
Osteopore debuts on the ASX following its well supported IPO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bec49824af20dff74434d1ce60c06f2 |
Admission to Official List
|
2019-09-27 13:37:32 |
Initial Director's Interest Notice x 4 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6e0e122909737bada33847b4f1632c6b |
Initial Director's Interest Notice
|
2019-09-30 08:17:51 |
Becoming a substantial holder notices x5 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/990afda7150a9984cc84adf001db00eb |
Becoming a substantial holder
|
2019-10-22 12:51:39 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c97d3dab8a337c2fbd272bbd30d29089 |
|
2019-10-31 18:56:54 |
Company Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/201d922ffc1d7eaaf1a943c01669bd49 |
Commitments Test Entity - Third Quarter Report
|
2019-11-19 10:14:12 |
OSX Executes Memorandum of Co-operation in Hainan Province |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ba4d28c297fa1801d8f175828e6569ca |
|
2019-11-26 16:48:43 |
Notice of Release from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d0fefe4afb8b29352ecdf60f01473f5 |
|
2019-12-04 09:29:26 |
Former President and CEO of Cochlear Joins as Board Advisor |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b48a44bdd5b0b144a746280ce3af08fe |
Company Administration - Other
|
2019-12-18 08:21:19 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d135f124d089055bc38a667b60bb890 |
|
2020-01-31 08:20:52 |
Company Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e5d482bf15df019f88ffda32ed0318b |
Commitments Test Entity - Fourth Quarter Report
|
2020-02-07 09:18:14 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa411f4352a08f1b179be0f755410371 |
|
2020-02-28 20:25:21 |
Appendix 4E Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/86f67a680b42564bbbd368443a85654c |
|
2020-03-10 19:21:17 |
Notice of Release from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e1d3d18b46757a37dae2e82bc78620b |
|
2020-03-24 20:10:04 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b4479aa230ae6c5eda9faf1daa6a2aac |
Appendix 2A (Application for Quotation of Securities
|
2020-04-01 08:15:02 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e9a64f32d3201750015b9d5014f53d9 |
Full Year Directors' Statement
Full Year Directors' Report
|
2020-04-01 08:16:08 |
Appendix 4G and Corporate Goverance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01e9f049d4cc52d9d19ca9a8cfea2649 |
|
2020-04-08 10:25:08 |
Company Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/abe90c0e9da60fb4af1670d7183c73d5 |
|
2020-04-16 12:10:08 |
Pause In Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ff584c44e667ff1990bd9dcc8fd07bb4 |
|
2020-04-16 12:26:21 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4df4f5ef636cb15b4a1883196863f968 |
|
2020-04-20 09:33:54 |
Osteopore Receives Australian TGA Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dcc78178d8286fbdfa8341a41e1e26b8 |
|
2020-04-30 18:27:14 |
Activities Update Quarter Ending March 2020 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e5aaad6f20735e298b58f3f57910ff8b |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2020-05-06 09:51:49 |
Proposed issue of Securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed3aba526d8546fa77eaaf0207e3ee3b |
|
2020-05-06 09:57:56 |
Proposed issue of Securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/98569877cfa89677f56ed8ee803fb66e |
|
2020-05-06 18:57:51 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f1bc43f0c05d613c5cf52a6f709a0474 |
Notice of Annual General Meeting
|
2020-05-19 15:54:49 |
Teleconference Details for Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de771b5e47844a1ae273b2854f5d47d0 |
Notice of Meeting - Other
|
2020-06-05 17:17:15 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ab2b8d65b392377f8e909b06ec64ec4b |
|
2020-06-11 18:55:51 |
Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a77c2a515389be2455aa96f5e4bba67 |
|
2020-06-11 18:55:53 |
Notice of Release from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bee1e010effd0c3621fc36653bc59a05 |
|
2020-06-23 18:41:39 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d7e3d32834f9cbc5150967dc10d62a49 |
Appendix 2A (Application for Quotation of Securities
|
2020-07-02 08:13:06 |
Osteopore Signs Initial U.S. Distribution Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f6a369b00bc9469ba87f0c3502acfc42 |
|
2020-07-02 10:50:43 |
Pause In Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4107786acfcaca19382ce7fe088d1d26 |
|
2020-07-02 12:03:54 |
Clarification on Initial US Distribution Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/05f4e336e4b78b1e3aeea17da812804d |
Company Administration - Other
|
2020-07-22 12:26:12 |
Development of New 3D Printed Bone Implant |
1 |
https://app.sharelinktechnologies.com/announcement/asx/448e56fc78cb270148fa9833a594fd9e |
|
2020-07-31 10:29:26 |
Activities Update Quarter Ending June 2020 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eeece4301e44078c999cfbf5db2ddcb1 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2020-07-31 14:18:05 |
Amended Activities Update Qtr Ending June 2020 and App 4C |
0 |
https://app.sharelinktechnologies.com/announcement/asx/400c3dbcc1ae7117edf03900b407daa6 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2020-08-19 09:16:13 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/59f591c596bdff6e4041b333fda58bd1 |
|
2020-08-21 10:12:49 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cca5fe1159aa9e41a2cf40112a9785e5 |
|
2020-08-21 10:12:52 |
Osteopore Receives Binding Commitments for $8.5m Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6ee306ea719630a9a17b187b2c6d5a41 |
|
2020-08-21 10:13:00 |
Proposed issue of Securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b31a8a6c900cc77841a76d86f3ee8ab5 |
|
2020-08-21 10:13:58 |
Proposed issue of Securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9391ed94c252aa153dc2704a7d58b51 |
|
2020-08-28 18:33:25 |
Completion of Placement and Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/38827625b4326c3e66b80644e4cf20a2 |
|
2020-08-28 18:35:27 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/95ea583dc38b9c5efd7a6ffefe459c61 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-08-28 18:36:28 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/801bc22feff7cd2059e0ff5e90d2df1d |
Appendix 2A (Application for Quotation of Securities
|
2020-08-31 18:07:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/152ac8a33c8024d75668ebb33e11c80c |
Half Year Directors' Statement
Half Year Directors' Report
|
2020-09-15 08:24:21 |
Collaboration Agreement to Develop Additional Product |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9241a3bfb2be4e82459423d1a41f5880 |
|
2020-10-29 14:56:42 |
Activities Update Qtr Ending September 2020 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/78b5468ef34851cfdb0d36f30a6c9fbe |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2020-10-30 13:55:53 |
OSX Signs Australian & New Zealand Distribution Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2fcc640a3ea9381fd00635c4612fc4b8 |
|
2020-11-02 19:15:02 |
OSX Appoints Ex-Resmed Finance Executive to CFO Position |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef20e8309c282f5f8a18ddd92f1ba1e0 |
Company Administration - Other
|
2020-11-19 19:21:16 |
Updated Quarterly Activities Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be09a5064cd92c5a8e2c85775b9972cd |
Commitments Test Entity - Third Quarter Activity Report
|
2020-11-23 10:04:02 |
Osteopore Signs Germany & Austria Distribution Agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9bcc0b9eb776c89aa8c1b595fc21bf4 |
|
2020-11-24 08:20:26 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9359e7741c1670e1df175412a09e9f37 |
|
2020-12-21 15:23:21 |
Change in substantial holding forms |
0 |
https://app.sharelinktechnologies.com/announcement/asx/25bf110a6168afed928ca1aafbb4e2f3 |
Change in substantial holding
|
2021-01-29 13:57:53 |
Activities Update Qtr Ending December 2020 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e175c5df3b7f896d7efd624fcc4a2a0b |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2021-02-01 09:47:44 |
Agreement with Terumo Blood and Cell Technologies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4ef3cb07b63022c902a33dbb7f2299f4 |
|
2021-02-26 15:45:40 |
Appendix 4E Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3955e279b65d40a72bfe1310bab9c7e2 |
|
2021-03-22 10:08:04 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/976eab157a7b0c7cde4434d477f59fa5 |
|
2021-03-25 17:57:47 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0724b7baa534fd137b09704878b66b0e |
Full Year Directors' Statement
Full Year Directors' Report
|
2021-03-25 17:58:52 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9160ce796d0355086acdfdf48bf8d4db |
|
2021-04-01 18:04:02 |
Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e4629a26369f94f684c9d14f2f9cf250 |
Notice of Meeting - Other
|
2021-04-27 08:22:53 |
Osteopore Granted Patent for Smart 3D Biomimetic Scaffolds |
0 |
https://app.sharelinktechnologies.com/announcement/asx/060945113d42498f298a00866051b14f |
|
2021-04-29 17:52:47 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/567a35b6b596de8562197475db855f92 |
Notice of Annual General Meeting
|
2021-04-30 09:45:41 |
Activities Update Qtr Ending March 2021 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/341c6c2ed49b6a085983b72e3b41ece3 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2021-05-10 08:52:42 |
Osteopore Expanded CE Listing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6322b10958feec743091f5323bea7c87 |
|
2021-05-14 19:00:58 |
AGM Teleconference Details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c669fa6b6af09040e5553bbefabf7456 |
Notice of Meeting - Other
|
2021-05-28 18:00:57 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2fb222605408ad47015f8d6c97c6f41c |
|
2021-06-10 10:06:04 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af8cbc537c478af0dd5989a77c7015f8 |
|
2021-07-02 18:59:37 |
Notification regarding unquoted securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f42c44da10dff5796635179e9dde11a5 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-07-16 18:32:28 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53cd7e193249eea4bd082964f9f275de |
Change in substantial holding
|
2021-07-30 16:50:37 |
Activities Update Qtr Ending June 2021 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/44bd5f8567fd90136a4827e41587f66c |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2021-08-02 09:20:16 |
Changes to Osteopore Board of Directors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ae4cde4953dcfd673293a2cea8305b0 |
Director Appointment/Resignation
|
2021-08-06 18:31:29 |
Appendix 3X and Appendix 3Z |
0 |
https://app.sharelinktechnologies.com/announcement/asx/810cdcb94b9aebe6d61d320b8959ff3e |
Initial Director's Interest Notice
Final Director's Interest Notice
|
2021-08-26 18:27:25 |
Osteopore Sponsors Australian Patient Trials |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7def9f8b5430b79263389030917fc235 |
|
2021-08-31 10:37:28 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cded53dd7468cbca0850dbbafe30129d |
Half Year Directors' Statement
Half Year Directors' Report
|
2021-09-16 18:53:49 |
Notice of Release from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50b788f9a646b03fdf109f4b3987f829 |
|
2021-09-23 19:05:04 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d749dc1283ab0f9b8f411011e6a1784 |
Appendix 2A (Application for Quotation of Securities
|
2021-10-08 09:56:53 |
Changes to Board of Directors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/23331895e45651c0fe653553ab8ee72b |
Director Appointment/Resignation
|
2021-10-13 19:07:03 |
Appendix 3X and Appendix 3Zs |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa7e7326c00284a9d4bbea2a15c7b8a8 |
Initial Director's Interest Notice
Final Director's Interest Notice
|
2021-10-19 08:24:45 |
CSIRO Collaboration for AI-based Tool |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ad9c85c496388591ee42da8d47a81391 |
|
2021-10-19 09:21:18 |
Osteopore collaborates with Singular Health Group |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09f24bd3ab8e2d5adf902fd783e41456 |
|
2021-10-29 11:28:25 |
Activities Update Qtr Ending September 2021 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0a1ace6637674d08b35b147e3e0d597f |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2021-11-02 08:35:04 |
Osteopore granted patent in China opening local opportunity |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec03bf684d61de79fc78605d7282ffdb |
|
2021-11-22 10:10:07 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f0d94a5775d8843f14d167912c87dff |
|
2021-12-02 09:13:08 |
Osteopore Receives Approval for Hong Kong Sales |
0 |
https://app.sharelinktechnologies.com/announcement/asx/903c44e6afc14222d2fc551493ab423d |
Company Administration - Other
|
2021-12-13 10:51:15 |
Osteopore secures A$19m clinical-industrial partnership |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a985007ad03bb821ff92d28cda4e8f97 |
|
2021-12-29 09:52:45 |
Change to the Board of Directors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8599f2608860afabffb60fe3f892d4eb |
Director Appointment/Resignation
|
2021-12-29 09:52:47 |
Appendix 3X |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d162528455387e13bc1b812df6f4f8a6 |
Initial Director's Interest Notice
|
2022-01-18 10:04:00 |
Chief Financial Officer Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fdb6023c278f2070cd43508e5f920242 |
Company Administration - Other
|
2022-01-28 10:09:07 |
Activities Update Qtr Ending December 2021 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/34726be13d6eed105b368ed61fdf2f2b |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2022-02-15 18:34:18 |
Resignation of Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f58757977f1e119318d1afba1534f363 |
Director Appointment/Resignation
|
2022-02-15 18:35:34 |
Appendix 3Z |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0398a23d0eaf382c11e8e4534c88ff7 |
Final Director's Interest Notice
|
2022-02-25 20:08:01 |
Appendix 3Y |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3dadd7a2bfe85580ab57f97523300af |
Change of Director's Interest Notice
|
2022-02-25 20:08:06 |
Notification of cessation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1422954435ef827bd19c51b87cca48ff |
Appendix 3H (Notification of cessation of securities)
|
2022-02-28 20:06:02 |
Appendix 4E Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/75a0cbe86c4ade07b52a9ff9d020be2b |
|
2022-03-14 08:19:32 |
SHG & CSIRO AI Tool to Optimise Cranial Implant Procedures |
1 |
https://app.sharelinktechnologies.com/announcement/asx/721304f7e8d431f28f763a4c1a6757c4 |
|
2022-03-14 09:27:25 |
OSX Commences AI-Powered Design Study for Cranial Implants |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c95d99828fd6aa97c5d0c25abe0f65b |
|
2022-03-31 20:06:54 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df13de960d82e1b12997c15f190644c1 |
Full Year Directors' Statement
Full Year Directors' Report
|
2022-03-31 20:06:58 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6c134c01b9c19f91fe3b896da427c9f7 |
|
2022-04-07 09:39:37 |
OSX Expands to Latin America with Initial Sales to Colombia |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b0ce0a5d9e4230e322f93b8977b9299 |
|
2022-04-07 19:05:04 |
Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a983c8fe38877f3b4a5f1509a82cba7a |
Notice of Meeting - Other
|
2022-04-14 09:18:15 |
OSX Expands Further into Europe with Initial Sales to Spain |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5e93bbf9c50ea6854502f2cf207d7be9 |
|
2022-04-28 09:53:51 |
Appointment of Chief Operating Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc811e03eaa5c68f98c28dc08af49b37 |
Company Administration - Other
|
2022-04-29 07:58:27 |
Activities Update Qtr Ending March 2022 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/22b2ec81fc5b3c93dd80f99e962139f9 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2022-04-29 17:39:34 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61e2278a0425c8d26ef3f016c0ae5891 |
Notice of Annual General Meeting
|
2022-05-10 09:50:47 |
OSX Enter Oral & Maxillofacial Market in Australia & NZ |
1 |
https://app.sharelinktechnologies.com/announcement/asx/80c35ab723dc7343c05af9981b13dde8 |
|
2022-05-31 19:18:14 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7946c41486ae6c92b3d2c3f1d7fdba6d |
|
2022-06-01 19:23:17 |
Employee Securities Incentive Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20d9a72da1789f571892aef7381fd48b |
Company Administration - Other
|
2022-06-01 19:25:20 |
Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0e45eba522364a20ee741de0ae06043 |
|
2022-06-14 08:14:05 |
OSX Expands into Africa with Initial Sales to South Africa |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebc103839742fd60f0f50b5cbdbba341 |
|
2022-06-15 19:16:14 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50d91ac1dd57186ec5e5bb56dbc36f7a |
Change of Director's Interest Notice
|
2022-06-20 11:29:27 |
Collaboration With Healthcare Group To Develop New Products |
0 |
https://app.sharelinktechnologies.com/announcement/asx/69fd5a04c3c88d392541877eb96c23eb |
|
2022-07-01 12:08:56 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c18284c2672198ff98bf40c88a11abbf |
Change of Director's Interest Notice
|
2022-07-04 09:24:24 |
Notification of cessation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5abd11c760258d3275ca1a8879da511d |
Appendix 3H (Notification of cessation of securities)
|
2022-07-25 10:13:08 |
Activities Update Qtr Ending June 2022 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cc375591f57341c59453b64e7bb683d9 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2022-08-01 07:53:43 |
Osteopore to Leverage on AI/VR to Enhance Market Access |
0 |
https://app.sharelinktechnologies.com/announcement/asx/336b696897d31ee223bcec3dd5245316 |
|
2022-08-01 08:50:46 |
Collaborative Agreement signed with OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e9a5f55e053acab2aeb16427f3a1205a |
|
2022-08-02 12:04:59 |
Clarification regarding collaboration with OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7b67ba93bbb970e5cda7bdd3b5f24c28 |
|
2022-08-03 09:47:44 |
Osteopore Gains Access to US Federal Healthcare Facilities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/895cb0a97c4e6c6f331138f355ddf83a |
|
2022-08-10 08:35:32 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93912900dbac18767b387200fab89729 |
|
2022-08-23 09:35:32 |
Osteopore Moves Closer to China Market Entry |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b522a68d2bda09d0d2e05f57ca465d85 |
|
2022-08-24 19:05:02 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c8d9adb09e42357fa1222eb02351ca3 |
Becoming a substantial holder
|
2022-08-24 19:06:04 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50a3a1339125cf04914e94e3e18b3844 |
Change in substantial holding
|
2022-08-31 18:49:43 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b34f3125a028274bfdd8da4929a6c714 |
Half Year Directors' Statement
Half Year Directors' Report
|
2022-09-28 08:52:47 |
More Osteopore Products Available on Prostheses List |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7378ef1063716649d10220fd57d17c47 |
Company Administration - Other
|
2022-09-28 11:10:05 |
Chile Government and University co-fund Osteopore research |
0 |
https://app.sharelinktechnologies.com/announcement/asx/119733a66061484fbfa8ed4f3bf8e212 |
|
2022-10-05 19:12:08 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65ef277bf30180037ff7bb0c93887277 |
Change in substantial holding
|
2022-10-05 19:13:09 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d1093064b907867878a90f06d51ad5a |
Ceasing to be a substantial holder
|
2022-10-31 09:26:22 |
Activities Update Qtr Ending September 2022 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9ba5650543b2eb30d9a9d07324250d9e |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2022-12-08 09:08:05 |
Increased presence and commercial opportunities across SEA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dbfc37fbc0ea7b030f56c9abe3987d41 |
|
2022-12-19 09:23:20 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a429f69f9697845a99c4e27e21e7bd9c |
|
2022-12-21 10:07:04 |
Suspension from Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d2727605f4393279ba55765b06e1ba99 |
Suspension from Official Quotation
|
2022-12-22 09:39:07 |
Firm Commitments and Non-Binding Proposed Acquisition |
1 |
https://app.sharelinktechnologies.com/announcement/asx/605badcabd4657051413bb6b5e92d264 |
|
2022-12-22 09:39:10 |
Proposed issue of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/632efd9585abce37ac793d5673195de4 |
|
2022-12-22 09:39:37 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e185265a4e80acd11ead4804fe3ee9c8 |
Reinstatement to Official Quotation
|
2023-01-03 18:05:04 |
Notification of cessation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61e1abc15d624adc4165294f2d1fe208 |
Appendix 3H (Notification of cessation of securities)
|
2023-01-04 17:54:53 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44359db697550eb11bdd7f517d1b22e4 |
Appendix 2A (Application for Quotation of Securities
|
2023-01-04 17:58:55 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae2682773e6b46e3677eb4f9c05a8a4f |
|
2023-01-23 08:24:36 |
Integration of Acquired Business for Higher Sales & Margin |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ea5d79e97a907163457feb3d0692738d |
|
2023-01-25 18:39:36 |
Appointment of Joint Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50701426a6e921edfc8e73c0584807c9 |
Company Secretary Appointment/Resignation
|
2023-01-31 10:15:09 |
Activities Update Qtr Ending December 2022 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cab8de57e8167d373fb0704976038472 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2023-02-14 08:55:53 |
OSX Enters Orthopaedic Market in Great Britain |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a631dfb3692ff43b9c8db8edfa4605c |
|
2023-02-20 09:47:39 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09fc665677978027c093f296d72817fd |
|
2023-02-27 09:04:01 |
Osteopore Advisory Panel of Distinguished Industry Leaders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/799087a0db1a42867ab2cafc23985261 |
Company Administration - Other
|
2023-02-28 18:42:39 |
Appendix 4E Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/96a7cce6a4344238f728867f8641606d |
|
2023-03-02 17:09:05 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca1e1b745eeb660209296fb7cf2aeb53 |
Notice of General Meeting
|
2023-03-13 08:42:39 |
Non-Renounceable Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e95f8ea19e79f692e98ad05a5e9885d9 |
|
2023-03-13 08:54:50 |
Non-Renounceable Entitlement Offer Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c2a37d322b4fc9783c1475dd85c5c497 |
|
2023-03-13 09:47:46 |
Proposed issue of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/38bb44fdb0de17497fbbcb5336ecc913 |
|
2023-03-13 09:47:52 |
Letter to Eligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9c794fe3abae85353fbd791793318f1 |
|
2023-03-13 09:48:53 |
Letter to Ineligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/963e509615289dac7905d96a625d4884 |
|
2023-03-13 09:49:54 |
Letter to Optionholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c0ba0518b368f6fb96fd22fb00f16cc |
|
2023-03-14 17:35:33 |
Update - Proposed issue of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/533c8d7ac858f3691503f4e8329a6b8c |
|
2023-03-21 18:40:38 |
Prospectus despatched |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83faa203ac0f2ddeddf53c2d3c790c95 |
|
2023-03-27 09:30:29 |
OSX Product Approved for Additional Applications in Taiwan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db053a6577b2472a0ff3e18ac4a6bb37 |
|
2023-03-30 11:25:23 |
Non-Renounceable Entitlement Offer Extension |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3005fa6fcc66d37026259a6d7e976fc |
|
2023-03-30 18:31:17 |
Update - Proposed issue of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f2c571f78ada143226d6f4eead71b5e5 |
|
2023-03-31 09:37:35 |
OSX Completes Acquisition to Accelerate Revenue Growth |
1 |
https://app.sharelinktechnologies.com/announcement/asx/58863aac631bc84ff7f3bd4125417481 |
|
2023-03-31 16:20:16 |
Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e18dd530941c9986c83b2a17710790da |
Full Year Directors' Statement
Full Year Directors' Report
|
2023-03-31 16:22:18 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/205b6d4e0ca40e9ca98f7ca29685626b |
|
2023-03-31 17:07:05 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1df3f624a4dcda26a831a60b64dcf30f |
|
2023-04-05 12:19:17 |
Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d137b00940b4718aacc2b9a4b2c8665b |
Notice of Meeting - Other
Company Administration - Other
|
2023-04-11 08:24:21 |
OSX Strengthens Presence in the Eastern Region of the USA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/308a224fcc59831bcd7cc854b2ddd3d4 |
|
2023-04-13 10:01:59 |
Non-Renounceable Entitlement Offer - Closing Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eefbc485355e933fe1b85496e9efb2e9 |
|
2023-04-13 19:15:14 |
Employee Securities Incentive Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/544b6934c097f1e1ffc3fe845d3a47fd |
Company Administration - Other
|
2023-04-14 09:12:09 |
Osteopore to Commercialise Innovative Bone Rengeneration Tec |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0c45b9ecd4c367f6c73850bc962d3b4 |
|
2023-04-14 18:37:29 |
Osteopore Increases Presence in Singapore Dental Market |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a22113501a85c2a191a7414ce350aae |
|
2023-04-24 09:42:35 |
Non-Renounceable Entitlement Offer - Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/366acc5e7b6bc0458190d1f946b8f67a |
|
2023-04-24 11:59:56 |
Security Class Suspension from Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/da7d8da396a02484b1ff8cd4a52cfece |
Suspension from Official Quotation
|
2023-04-24 12:01:59 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2172b03369766c551c0daaeef8f2ac78 |
Appendix 2A (Application for Quotation of Securities
|
2023-04-24 18:21:19 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48f9d2ccfc1504f923afb1bd2e91f0d6 |
Appendix 2A (Application for Quotation of Securities
|
2023-04-26 07:48:13 |
Top 20 and Distribution List - Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b589f41fce7e26923fe58f43c7b114c3 |
|
2023-04-26 07:49:22 |
Reinstatement of Security Class to Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c714360144b4dd12273f64e3b8a0d39a |
Reinstatement to Official Quotation
|
2023-04-27 08:30:28 |
OSX Successfully transitions to EU Medical Device Regulation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ba01ec7b99629f84cbb80b648dd20dc0 |
|
2023-04-28 08:24:10 |
Activities Update Qtr Ending March 2023 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/99a94511471939401e1da509b91f8233 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2023-04-28 09:26:21 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6cb2c8dcd16893a8abf1c513dc1b4fa3 |
Notice of Annual General Meeting
|
2023-04-28 18:38:33 |
Change of Director's Interest Notice - ML |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e278c426da182f0cb2c9c02c636bd100 |
Change of Director's Interest Notice
|
2023-04-28 18:39:38 |
Change of Director's Interest Notice - TSH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b907ec7a4be529bd303fd4a0f71adbe2 |
Change of Director's Interest Notice
|
2023-05-05 14:50:48 |
Change of Registered Office |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72005c050dd53c6e2155cbe61f9392c8 |
Details of Company Address
Details of Registered office address
|
2023-05-12 16:27:26 |
Notification regarding unquoted securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/187fc31e315d520f6643d7921ad59b46 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-05-16 08:19:16 |
Largest South African Medical Insurer provides cover for OSX |
1 |
https://app.sharelinktechnologies.com/announcement/asx/62cde9a614c8fae3542d11e945f3b158 |
|
2023-05-25 18:38:36 |
Notification regarding unquoted securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/216fc32d4119f4b7e6b45dd440b86a3d |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-05-30 17:45:43 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/39777a5f22e9fd94e57db81a48872a6b |
|
2023-06-08 08:54:52 |
Strategic Partnership for Clinical R&D in China worth $4M |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3525f548ad996f8cd0aafdd61c0206c6 |
|
2023-06-20 08:45:43 |
Shortfall oversubscribed for Osteopore's Global Expansion |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0951dce668871fcbe3f74bac1b8f7135 |
|
2023-06-23 16:38:35 |
Change of Share Registry Details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31144bfdfa9364161b3230ee0a685dcd |
Details of Share Registry address
|
2023-06-26 18:21:15 |
Notice of Breach of ASX Listing Rule 10.11 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/adf5761593cf5f2ddfe678dc8cb20b4b |
Company Administration - Other
|
2023-06-29 15:14:13 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a1450a00727ef85ee01086f52446a590 |
Appendix 2A (Application for Quotation of Securities
|
2023-07-07 17:16:11 |
Rectification of Breach of ASX Listing Rule 10.11 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/830afb18d305c81f8ac35a993d28b07f |
Company Administration - Other
|
2023-07-07 18:33:31 |
Change of Director's Interest Notice - ML |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1aae66610ae8bd55bf2a0e1e21958c8d |
Change of Director's Interest Notice
|
2023-07-18 08:42:39 |
Osteopore strengthens Board & Management by key appointments |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4a11b0f49ee5a8cc43282e756aecc265 |
Director Appointment/Resignation
Company Administration - Other
|
2023-07-25 08:41:38 |
OSX receives A$10m commitment for commercialisation in China |
1 |
https://app.sharelinktechnologies.com/announcement/asx/37980f51c6513bf22dc771855f85082e |
|
2023-07-31 08:46:43 |
Activities Update Qtr Ending June 2023 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/11cb86da91bf2797c6ddd875bd5ca092 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2023-07-31 16:38:35 |
Initial Director's Interest Notice - MK |
0 |
https://app.sharelinktechnologies.com/announcement/asx/47877915e347d1de40ebfde8e720928d |
Initial Director's Interest Notice
|
2023-08-01 10:34:31 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d68e08cf304784690d1e49ba9c53bd2 |
|
2023-08-01 16:13:07 |
Clarification Announcement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1028e5779cfc360770d9d6246031b6d8 |
|
2023-08-28 18:13:11 |
Notification of cessation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8bc04a55b5b4b08da1047c0d90d4609 |
Appendix 3H (Notification of cessation of securities)
|
2023-08-29 19:06:02 |
Timeline extended for definitive agreements with CellHeal |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a23ab239cadedc5600663c5318426e1 |
|
2023-08-31 17:29:22 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5eee795fe21ef461a9b481b7f3d1dda8 |
Half Year Directors' Statement
Half Year Directors' Report
|
2023-09-04 17:38:30 |
Resignation of Joint Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd3a4fef41407bf116c9d0b30f80d2fc |
Company Secretary Appointment/Resignation
|
2023-09-12 08:20:58 |
MOU with Temasek-linked Innoventures - Orthopaedics in China |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6a480b27651fa518a6c561f3abc3c903 |
|
2023-09-18 08:58:56 |
Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/edb8bbe9075d165c0a79b1ef08fc86e7 |
|
2023-09-18 11:25:20 |
Clarification Announcement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ffe0346765b7d2b0d7bc7ffb5606a4b |
|
2023-10-05 19:31:27 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/982d189f518c13912e41776b539ee739 |
Change of Director's Interest Notice
|
2023-10-31 08:15:38 |
Activities Update Qtr Ending September 2023 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8f238497ce9f5148d349224067448e6c |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2023-11-30 17:52:49 |
Negotiation ongoing for InnoVentures Definitive JV Agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ab1093c5f15362479384860e0d7bf740 |
|
2023-12-05 16:27:26 |
Change of Director's Interest Notice - TSH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31fd4bfed34507bfe6d164f2726268e5 |
Change of Director's Interest Notice
|
2023-12-18 09:55:52 |
Osteopore secures Hainan Approval for Neurosurgery |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed8e408edc027b5dfc9974f01a2cdb55 |
|
2023-12-28 19:36:32 |
Osteopore signs Bridging Loan agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9d2d553e8e52306fa058b7049aa45d0d |
|
2024-01-23 12:03:02 |
Consolidation/Split - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48ce17e1aebd218a4f0923a9a3961c81 |
Alteration to issued capital
|
2024-01-23 12:03:56 |
Notice of General Meeting |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cb9a2cb8486d251c50900c7fab7fef2c |
Notice of General Meeting
|
2024-01-29 08:20:19 |
OSX achieves 100k implants, to accelerate commercialisation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce988808eb3b2fa18d95c542c0a62ead |
|
2024-01-31 08:59:53 |
Activities Update Qtr Ending December 2023 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b8914bfc886b8c6f35b3e5ef4fcc0385 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2024-02-21 20:19:14 |
OSX advances capital consolidation for long-term growth |
0 |
https://app.sharelinktechnologies.com/announcement/asx/58cb66bb418ae2ffb498363efa02d283 |
|
2024-02-29 18:02:45 |
Appendix 4E Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/10d48a30ea7e93ba7d0b932bba8bea2c |
|
2024-03-04 08:16:22 |
Completion of Consolidation of Capital |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64ff29d96130433728d29de606321b33 |
|
2024-03-04 09:24:27 |
Update - Consolidation/Split - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18758007985df0b4f2a2e2824ca38b26 |
Alteration to issued capital
|
2024-03-06 20:01:00 |
Appendix 3Y - Change of Director's Interest Notice x 3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/47c0cc341e78dc191d928a4fbfb3a11d |
Change of Director's Interest Notice
|
2024-03-13 09:28:26 |
OSX Entitlement Offer to support growth |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d91766faad3c31ea737bee6ac7a4f08e |
|
2024-03-13 09:30:28 |
Prospectus for Renounceable Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d0fd85b49cd6f1eb978aecf6cebc5db5 |
|
2024-03-13 09:32:31 |
Proposed issue of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3a3b48d2b5405125b20b8947d450dcde |
|
2024-03-13 13:54:52 |
Update - Proposed issue of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a6fd232fdc34b52f8a8370af400b3a6 |
|
2024-03-19 11:20:18 |
Prospectus despatched |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0113aa58cf6ebeceb30fac1407b39b2b |
|
2024-03-19 11:34:20 |
Letter to Eligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/80851cef19dabc175440074511862726 |
|
2024-03-19 11:35:21 |
Letter to Ineligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/733de95e339434f624a00cd7bd23bfaa |
|
2024-03-26 08:39:38 |
Osteopore progresses Australian bone scaffold trials |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87d416e890cd5664e1080df35df3b00a |
|
2024-03-27 08:22:16 |
Osteopore secures Singapore and Vietnam market approvals |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9720d721aecbbeb12f2a5f8ebc617816 |
|
2024-03-27 16:14:09 |
Amendment - OSX Singapore and Vietnam market approvals |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5be7980b786d50c0e14acd122772768b |
|
2024-03-28 09:32:30 |
Suspension from Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f560273a9eaf415c19cc348035c9ee53 |
Suspension from Official Quotation
|
2024-04-02 09:40:32 |
Suspension from Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/03d64f73f68889b4dd05d29cdaa869e6 |
|
2024-04-02 20:11:05 |
Replacement Prospectus for Renounceable Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a181526e83dbe54da9085b71e7bda955 |
|
2024-04-02 20:14:06 |
Letter to Eligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88f4497d6924d58880154dc635fa2aae |
|
2024-04-02 20:15:08 |
OSX issues Replacement Prospectus for Entitlement Offer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f44ab84a4ba45e69f3737132848aaf16 |
|
2024-04-02 20:20:09 |
Update - Proposed issue of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/140f1f255ab2b5408b77d4c57b09da6e |
|
2024-04-03 20:15:07 |
Update to Replacement Prospectus for Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8d6837c52489a292b05e9623045ec181 |
|
2024-04-04 20:20:11 |
Replacement Prospectus for Renounceable Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/08a592ac6f97e98547fcf25e0e9667b5 |
|
2024-04-04 20:21:13 |
Update - Proposed issue of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e268a73e553423d649d5fe5fd7850bad |
|
2024-04-05 18:22:57 |
Osteopore announces 97% take-up for Entitlement Offer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03dfdf44139735afc345a927aeb84e24 |
|
2024-04-05 19:13:04 |
Update - Proposed issue of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fcce5054156c6a645a0589966f5c973a |
|
2024-04-05 20:18:50 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2645fc676557365c71109494b7daa49c |
Ceasing to be a substantial holder
|
2024-04-08 16:51:44 |
Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1af8fae18d37ede47f9082bf898ed23a |
Notice of Meeting - Other
Company Administration - Other
|
2024-04-10 15:57:51 |
Osteopore extends Bridging Loan maturity date |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8d150542e9ee2d69c7dc83b46c8f5519 |
|
2024-04-15 11:29:21 |
Response to ASX Query Letter |
1 |
https://app.sharelinktechnologies.com/announcement/asx/67fa144af0c8fb688d18ccf6f541bc62 |
|
2024-04-16 18:55:48 |
Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/818fe64c19ccf40e361be878cc99f46f |
Full Year Directors' Statement
Full Year Directors' Report
|
2024-04-16 18:55:49 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4aa6f392ad96a9ce6ce08bed8da0e685 |
|
2024-04-16 19:01:03 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3c08ce24bbc39acedc2f476844a84933 |
Reinstatement to Official Quotation
|
2024-04-23 09:14:12 |
First-in-human clinical trials begin in Singapore |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a0a152e05564b8ee65e7130dd794b19 |
|
2024-04-23 10:52:51 |
Pause in Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f19eb8edcb51b1387b1f36d54cb2347 |
|
2024-04-23 11:42:40 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2645f9e13c8b83af1b35eac95b60bf22 |
|
2024-04-23 12:47:44 |
Response to ASX Price and Volume Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/258605385483f6929333b61bfc65c50b |
|
2024-04-29 11:10:06 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44a515166b0229945f21b5bf7b8a09d1 |
Notice of Annual General Meeting
|
2024-04-30 09:11:05 |
Activities Update Qtr Ending March 2024 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de84eb2b11d95308db925b97141a386d |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2024-05-07 19:19:18 |
Osteopore successfully raises A$2.9m from Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/342b26b7f1baf777d17cb334c4023cb0 |
|
2024-05-08 11:15:11 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ab9b24f6f8322d07dd4110453288502 |
Appendix 2A (Application for Quotation of Securities
|
2024-05-08 11:15:14 |
Notification regarding unquoted securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/22a79540568a35c0497affb094566ed2 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-05-14 09:33:20 |
OSX and SingHealth partner on Global Centre of Excellence |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b68806437fec3f00c701902bb629df78 |
|
2024-05-15 18:54:51 |
Appendix 3Y - Change of Director's Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b84df2fa19efb0299065f60cd77a2f2 |
Change of Director's Interest Notice
|
2024-05-17 17:44:42 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/395186a77de6d1e022b446c25cb53cce |
Becoming a substantial holder
|
2024-05-20 12:17:16 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0357901c11b04d8a00320b879bc861d6 |
Ceasing to be a substantial holder
|
2024-05-20 18:10:08 |
Company Secretary Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb28a4dc4a29b397c12861525eb3e35e |
Company Secretary Appointment/Resignation
|
2024-05-23 11:43:42 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/050dd751fe96160ffd7d9f13f6a02cf7 |
Appendix 2A (Application for Quotation of Securities
|
2024-05-23 11:45:44 |
Options Exercised and Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c94015f658f3752b90e10d85aa43ac3 |
|
2024-05-23 19:09:06 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c78c6d7cb06f89bc41a2b00b76692a59 |
Becoming a substantial holder
|
2024-05-27 18:54:54 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbc0803ba3bef0befd537ffeb80fac25 |
Appendix 2A (Application for Quotation of Securities
|
2024-05-27 18:59:57 |
Options Exercised and Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/520281f9ea1f9e07176b0180ed1534a4 |
|
2024-05-30 14:49:48 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19f59213690c5e27ac00c35e470cc2b1 |
|
2024-06-05 19:01:00 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65bf71cb69f3c19f2a509b5a997767fb |
Appendix 2A (Application for Quotation of Securities
|
2024-06-06 09:13:11 |
A$18.7m Osteopore, NDCS and A*STAR project hits milestones |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ac2fa232f57d79520a67dc29d2033a3d |
|
2024-06-12 18:22:21 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/febe5f4a28ee3f605ad85a8b4ae6bcfd |
Appendix 2A (Application for Quotation of Securities
|
2024-06-19 18:34:33 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ebb9e1c37c173b539863e38369dddde |
Appendix 2A (Application for Quotation of Securities
|
2024-06-26 18:53:52 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/797f9190f0df35c04f930a55cbd3215b |
Appendix 2A (Application for Quotation of Securities
|
2024-07-03 18:30:30 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a60b5bb2b4f80c6a96a96bc768f36d8 |
Appendix 2A (Application for Quotation of Securities
|
2024-07-11 16:32:31 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2f10043fa8edfcfda49c14a8f34a902 |
Appendix 2A (Application for Quotation of Securities
|
2024-07-16 08:47:45 |
Osteopore strikes Exclusive Distribution with Zimmer Biomet |
1 |
https://app.sharelinktechnologies.com/announcement/asx/927633dd316da7c2e38fddd6bda45a15 |
|
2024-07-17 18:33:33 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/95962644b67f125c751c04190546847b |
Appendix 2A (Application for Quotation of Securities
|
2024-07-26 18:26:25 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09c1cc56f32ec179a6816590ee92b9e7 |
Ceasing to be a substantial holder
|
2024-07-31 08:30:28 |
Activities Update Qtr Ending June 2024 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4405bca12362fed7dd1b84fbb644308b |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2024-07-31 17:43:42 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9114e2a8369bd8306feafd4e33b708b7 |
Appendix 2A (Application for Quotation of Securities
|
2024-08-22 08:20:53 |
OSX and University of Chile complete bone implant studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/11b998e2a741c42b3bcd3c97cdfaf283 |
|
2024-08-30 17:06:59 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9097cd27fa295205df49cdc5ca5ec563 |
Half Year Directors' Statement
Half Year Directors' Report
|
2024-09-24 08:26:21 |
Appointment of Executive Director - Dr Yujing Lim |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d45eac983530164cf9dcac68964cbea |
Director Appointment/Resignation
|
2024-09-25 18:51:49 |
Initial Director's Interest Notice - Yujing Lim |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f7b23268cf3a03a41e96bae4414354db |
Initial Director's Interest Notice
|
2024-09-26 12:30:29 |
Revised Initial Director's Interest Notice - Yujing Lim |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d13fc2fd9c8914269a7c729331961d4d |
Initial Director's Interest Notice
|
2024-09-27 08:30:28 |
Osteopore to raise A$20m via redeemable convertible note |
1 |
https://app.sharelinktechnologies.com/announcement/asx/58754c4f69ee029c4684f10a63c38d82 |
|
2024-10-10 09:04:03 |
Osteopore strikes scaffold-based iPSC deal with RxCell |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b3c6b909dec8890787baf06ad06d06df |
|
2024-10-17 09:56:53 |
Osteopore strikes collaboration with NASDAQ-listed CytoMed |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a87e1d32352d7757c7e1c01977f49ec |
|
2024-10-24 09:04:03 |
Osteopore Secures Brazilian Craniofacial Distribution Deal |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a9c05d2237d8e2898ed3304838d6b94 |
|
2024-10-31 09:08:06 |
Activities Report September 2024 and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a0f9f6eab1b6ce8bf50d24ae9cf27e5d |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2024-11-01 19:28:27 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb821c39331b22765ec40a8cc42e13e2 |
Appendix 2A (Application for Quotation of Securities
|
2024-11-04 09:25:21 |
OSX partners scientists to drive regeneration innovation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/331b81d4962ccfa4d79ed92a8d5a216e |
|
2024-11-06 09:09:08 |
Osteopore inks DKSH deal to sell ortho products in Singapore |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e8b8d307f58219961edb3e5d5a223ab |
|
2024-11-15 17:26:25 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2ca19839c2c97690fd0ba75d50b9bac |
Appendix 2A (Application for Quotation of Securities
|
2024-11-19 19:10:09 |
Application for quotation of securities - OSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5e431a72c08d6ae69571b3ad4e9259c |
Appendix 2A (Application for Quotation of Securities
|
2024-11-21 15:26:24 |
Notice of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae66858983c3d030da9d7c6780fd9e19 |
Notice of General Meeting
|